Longitudinal tau and metabolic PET imaging in relation to novel CSF tau measures in Alzheimer’s disease

PURPOSE: Studies comparing CSF and PET tau biomarkers have included only commercial CSF assays examining specific phosphorylation sites (e.g. threonine 181, P-tau(181p)) and mid-domain tau (i.e. total tau, T-tau). Moreover, these studies did not examine CSF tau levels in relation to cerebral glucose...

Descripción completa

Detalles Bibliográficos
Autores principales: Leuzy, Antoine, Cicognola, Claudia, Chiotis, Konstantinos, Saint-Aubert, Laure, Lemoine, Laetitia, Andreasen, Niels, Zetterberg, Henrik, Ye, Keqiang, Blennow, Kaj, Höglund, Kina, Nordberg, Agneta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451715/
https://www.ncbi.nlm.nih.gov/pubmed/30610252
http://dx.doi.org/10.1007/s00259-018-4242-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6451715/
https://www.ncbi.nlm.nih.gov/pubmed/30610252
http://dx.doi.org/10.1007/s00259-018-4242-6

Ejemplares similares